Northwestern site for testing new treatments and markers for neurological conditions
Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT site)
This program helps bring Phase 2 testing of new treatments and biological markers to adults and children with neurological conditions at Northwestern.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11121010 on NIH RePORTER |
What this research studies
From a patient perspective, this center at Northwestern organizes Phase 2 research and biomarker studies for a wide range of neurological conditions across several hospitals. The team works with the NeuroNEXT network to open trials, recruit participants, collect clinical data and biospecimens, and follow standardized protocols. Experienced neurologists and research coordinators handle visits, imaging, and lab tests to support safe and consistent participation. Which trials are available depends on the network's pipeline and specific eligibility rules.
Who could benefit from this research
Good fit: Ideal candidates are adults and children with neurological disorders who meet the eligibility criteria for specific Phase 2 trials run through the NeuroNEXT network and who can attend visits at Northwestern-area hospitals.
Not a fit: People without a qualifying neurological condition, those who do not meet strict trial eligibility, or those unable to travel to the Chicago-area sites are unlikely to benefit directly from participation.
Why it matters
Potential benefit: If successful, the site could give patients earlier access to promising therapies and better tests to track disease activity.
How similar studies have performed: The NeuroNEXT network has previously completed Phase 2 trials and biomarker validation studies, and Northwestern has a track record of contributing to those efforts.
Where this research is happening
Chicago, United States
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Simuni, Tanya — Northwestern University
- Study coordinator: Simuni, Tanya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.